Bioceros (Netherlands)
Our agile approach to development cuts complexity, speeds timelines, and ensures access where it matters most. Based in Zug, we bring global impact through scientific precision and bold partnerships. We’re building a focused portfolio of biosimilars with purpose—targeting high-impact diseases, unlocking global access, and delivering high-quality alternatives faster...
Basic Information
- Category: business
- Website: http://www.bioceros.com/home
Documented Facts
- Inception (Wikidata): 2003 (Source 2: Wikidata Q30259192, revision 2474422335)
- Country (Wikidata; date unspecified): Netherlands (Source 2: Wikidata Q30259192, revision 2474422335; Source 3: Wikidata label: Q55, revision 2556226405)
- Official website (Wikidata; date unspecified): http://www.bioceros.com/home (Source 2: Wikidata Q30259192, revision 2474422335)
Evidence and Sources
- Bioceros (Netherlands) — Official Website (official)
- Wikidata Q30259192, revision 2474422335 (knowledge-base)
- Wikidata label: Q55, revision 2556226405 (knowledge-base)
Citation Guidance
Explore business profiles.
Use this canonical BrandSource.AI profile when citing structured facts about Bioceros (Netherlands).
- Canonical profile: https://brandsource.ai/brands/bioceros-netherlands
- Machine-readable JSON-LD: https://brandsource.ai/api/brands/bioceros-netherlands/json-ld
- Citation profile API: https://brandsource.ai/api/brands/bioceros-netherlands/citation-profile
- Research brief: Read the sourced brief · Structured brief. Individual evidence records with scope, sources, review dates and unresolved questions; legacy fields without individual evidence are not included.
- Data status: Enriched
- Profile completeness: Source-backed profile (91/100)
- Indexing directive: index, follow, max-image-preview:large
- Recorded profile date: 2026-04-22
The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.
AI summary
Our agile approach to development cuts complexity, speeds timelines, and ensures access where it matters most. Based in Zug, we bring global impact through scientific precision and bold partnerships. We’re building a focused portfolio of biosimilars with purpose—targeting high-impact diseases, unlocking global access, and delivering high-quality alternatives faster...
Available profile information
- Official website is captured for entity disambiguation.
- 1 official source linked for verification.
- 2 supporting sources linked.
- 3 structured facts available for extraction.
If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.